GlassScriptPhysician profile
Hillary Wilson
NPI 1689743700
$1,517.77
in general payments reported to CMS, 2019-2025
26 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $83.80 · 2023: $138 · 2024: $184 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,433.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.65 | 2022-2025 | |
| Lilly USA, LLC | $175.04 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $153.67 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $118.63 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Kite Pharma, INC. | $104.49 | 2025 | Yescarta |
| Glaxosmithkline, LLC. | $99.73 | 2025 | Trelegy Ellipta |
| Boston Scientific Corporation | $77.64 | 2024-2025 | Lumenis Pulse 120h, General - Pain Management |
| Amgen INC. | $75.13 | 2025 | Repatha, Otezla, Krystexxa |
| Exact Sciences Corporation | $67.95 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $62.77 | 2022-2025 | |
| Stryker Corporation | $40.94 | 2025 | Mako |
| Janssen Pharmaceuticals, INC | $39.26 | 2023-2025 | Spravato |
| Sanofi-Aventis U.S. LLC | $38.53 | 2025 | |
| Axsome Therapeutics, INC. | $35.49 | 2025 | Symbravo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.05 | 2023-2025 | Xifaxan |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $27.53 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $24.79 | 2024 | Voquezna |
| Xeris Pharmaceuticals, INC. | $24.65 | 2025 | Recorlev |
| Dexcom, INC. | $23.14 | 2023 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $22.91 | 2025 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $21.26 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $18.88 | 2023 | |
| Medtronic, INC. | $16.30 | 2025 | Inceptiv |
| Antares Pharma, INC. | $15.76 | 2024 | Xyosted |
| Otsuka America Pharmaceutical, INC. | $15.13 | 2025 | Rexulti |
| Sonex Health, INC. | $5.45 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.